US Broker Ratings

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Healthcare with a Potential 33.99% Upside

Enhabit, Inc. (NASDAQ: EHAB) operates within the healthcare sector, focusing on providing comprehensive home health and hospice services in the United States. With a market capitalization..

ATAI Life Sciences (ATAI) Stock Analysis: Exploring a 224.91% Potential Upside

ATAI Life Sciences N.V. (NASDAQ: ATAI) has been garnering significant attention in the biotech sector, particularly for its pioneering approach in the mental health treatment arena...

Upstream Bio, Inc. (UPB) Stock Analysis: Unveiling a 343% Upside Potential in Biotechnology

In the dynamic world of biotechnology, Upstream Bio, Inc. (NASDAQ: UPB) stands out with its significant potential upside of 343.45%, making it a compelling subject for..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 63.54% Potential Upside Amid Healthcare Innovation

AngioDynamics, Inc. (ANGO), a prominent player in the healthcare sector, is capturing investor attention with a compelling potential upside of 63.54%. This medical technology company, headquartered..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Exploring a 266% Potential Upside in Biotech Innovation

MeiraGTx Holdings plc (NASDAQ: MGTX) is capturing the attention of investors with its promising position in the biotechnology sector, focusing on the development of genetic medicines..

Altimmune, Inc. (ALT) Stock Analysis: Unveiling a 333% Potential Upside Amid Biotech Innovations

Altimmune, Inc. (NASDAQ: ALT) is drawing attention in the biotech sector with its promising portfolio of treatments for obesity and metabolic diseases. The clinical-stage biopharmaceutical company,..

Tourmaline Bio, Inc. (TRML) Stock Analysis: Exploring a 239% Potential Upside in Biotech Innovation

Tourmaline Bio, Inc. (NASDAQ: TRML) stands out as a significant player in the biotechnology sector, with a focus on developing groundbreaking treatments for immune and inflammatory..

Simulations Plus, Inc. (SLP) Stock Analysis: Unveiling a 104% Potential Upside in the Healthcare Tech Space

Simulations Plus, Inc. (NASDAQ: SLP) stands out in the healthcare sector, specifically within the health information services industry, as a promising investment opportunity. Headquartered in Lancaster,..

KalVista Pharmaceuticals (KALV) Stock Analysis: Unveiling a 120% Upside Potential

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its promising upside potential and pivotal advancements..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 144.88% Potential Upside

Tilray Brands, Inc. (NASDAQ: TLRY), a prominent name in the healthcare sector, specifically in the specialty and generic drug manufacturing industry, currently presents a unique opportunity..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: A Potential 98% Upside for Biotech Investors

ArriVent BioPharma, Inc. (NASDAQ: AVBP), a burgeoning player in the biotechnology sector, is currently drawing significant attention from investors due to its promising pipeline and a..

Definitive Healthcare Corp. (DH) Stock Analysis: Navigating a 1.74% Upside with Strategic Insight

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services industry, offers a robust SaaS platform that provides pivotal insights into healthcare provider..

AbCellera Biologics Inc. (ABCL) Stock Analysis: A Biotech Play with 121.80% Potential Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a Vancouver-based biotechnology firm specializing in antibody-based medicine discovery, is making waves in the healthcare sector. Despite a challenging financial landscape,..

Embecta Corp. (EMBC) Stock Analysis: A Promising 80% Upside Potential in the Healthcare Sector

Embecta Corp. (EMBC), a stalwart in the healthcare sector, offers intriguing prospects for investors seeking exposure to the medical instruments and supplies industry. With a market..

Relay Therapeutics, Inc. (RLAY) Investor Outlook: Potential 282.92% Upside in Biotech Innovation

Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage precision medicines company, is making waves with its innovative approach to drug discovery in the biotechnology sector. Based in..

Semler Scientific, Inc. (SMLR) Stock Analysis: Navigating Challenges with Innovative Medical Devices

Semler Scientific, Inc. (NASDAQ: SMLR) operates within the dynamic healthcare sector, focusing on medical devices designed to enhance the clinical efficiency of healthcare providers. Based in..

Bicara Therapeutics Inc. (BCAX) Investor Outlook: A Biotech Stock with a 261% Upside Potential

Bicara Therapeutics Inc. (NASDAQ: BCAX), a promising player in the biotechnology sector, is drawing significant attention from investors due to its innovative approach to cancer treatment..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating a 31% Potential Upside Amidst Market Challenges

Fortrea Holdings Inc. (FTRE), a nascent player in the healthcare sector, specifically within the biotechnology industry, commands attention with its remarkable potential upside of 31.05% despite..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 62% Upside Potential

Treace Medical Concepts, Inc. (TMCI) is capturing the attention of investors with its promising growth potential in the healthcare sector, specifically within the medical devices industry...

Personalis, Inc. (PSNL) Stock Analysis: Exploring Growth in the Diagnostics & Research Sector

In the rapidly evolving world of healthcare, Personalis, Inc. (NASDAQ: PSNL) stands out as a dynamic player in the diagnostics and research industry. With a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds